A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.
The drug, cabazitaxel (kuh-BAH-zuh-TAX-uhl), helped men live an average of 10 weeks longer in a large study sponsored by the drug's maker, Sanofi-Aventis. Researchers hope the drug can make more of a difference in men who aren't so sick. The federal Food and Drug Administration has said it will give the drug fast review.
U.S. Health and Human Services Secretary Kathleen Sebelius reiterated Tuesday that she won’t intervene in the “incredibly agonizing” case involving a 10-year-old Pennsylvania girl who is waiting for a lung transplant, telling members of Congress that medical experts should make those decisions.
One of the first provisions of the 2010 health reform law has had its intended effect: shifting costs from hospitals, taxpayers and families to health insurance companies, researchers reported on Thursday. It’s one of the most popular aspects of the law.
People may realize that fast food isn’t health food, but they don’t realize just how fattening it really is, researchers report. They surveyed people eating at 10 burger, chicken, sandwich and doughnut chains and found they greatly underestimated just how much they were chowing down.
A new line of caffeinated chewing gum is causing jitters among health advocates and prompting federal officials to take a new look at the proliferation of jolt-infused foods, including those marketed to children and teens.